Is Viking Therapeutics Stock Going to $50? Bulls and Bears
A wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...
Compare Glide Path and Equal Weight strategies to understand which fits your retirement goals. Learn key differences, risks, and practical steps to apply in your portfolio.
26,213 articlesA wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
VOO faces a delicate setup as rates hover near multi-year highs and the index’s mega-cap tilt looms. Two signals coul...
Novo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
A Sunrun co-founder disclosed the sale of 50,000 shares, prompting questions about timing and implications. This arti...
Investors chasing reliable profits often look for markets with strong rent demand and balanced growth. This article b...
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Caterpillar has emerged as a heavyweight in the Dow, powered by AI-driven infrastructure demand and mining activity. ...
Regulators are weighing changes to mortgage asset rules, yet banks may take time to adjust. In the near term, mortgag...
With summer on the horizon, investors wonder if XLE should ride along in their portfolios. This guide weighs the case...
Artemis II tightens the horizon for space infrastructure spending as major primes and component makers post strong ba...
When choosing between State Street Energy Select Sector SPDR ETF (XLE) and Vanguard Energy ETF (VDE), you’re weighing...